Innate Pharma S.A. (EPA:IPH)
France · Delayed Price · Currency is EUR 1.588
-0.006 (-0.38%)
Sep 11, 2026, 5:35 PM CET
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of €149.15 million as of September 11, 2026. Its market cap has decreased by -8.99% in one year.
Market Cap
149.15M
Enterprise Value
137.41M
Revenue
9.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.59
ChartMarket Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 149.15M, an increase of 18,728.95%. That is a compound annual growth rate of 30.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 149.15M | 1.00% |
| Dec 31, 2025 | 147.67M | -7.67% |
| Dec 31, 2024 | 159.94M | -24.29% |
| Dec 29, 2023 | 211.24M | -19.93% |
| Dec 30, 2022 | 263.84M | -24.98% |
| Dec 31, 2021 | 351.67M | 28.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Valneva SE | 547.70M |
| Valerio Therapeutics Société anonyme | 344.62M |
| Transgene | 241.29M |
| Cellectis | 191.49M |
| Sensorion | 117.36M |
| ABIONYX Pharma | 77.90M |
| Adocia | 71.38M |
| OSE Immunotherapeutics | 63.69M |